Current Edition

COVID-19

Drug price hikes moderate as rebates rise, report finds

Dive Brief: List prices of branded drugs in the U.S. rose by an average of nearly 5% last year, according to a report released Thursday …

Continue Reading →
bottomed out

After years of decline, drugmakers’ price hikes may have bottomed out

Double-digit list price increases for branded medicines in the middle of the last decade put drugmakers in political crosshairs. Under criticism and pressure, those boosts …

Continue Reading →